Previous studies demonstrated that activation of EMT- and TGF-β–related pathways could lead to a decrease of lymphocyte cells into tumor parenchyma (Galon and Bruni, 2019) and a weakness of their cytotoxicity effects (Salmon et al., 2012), which were considered T-cell suppressive. This evidence concerns the gene TGFB1 and neoplasm.